Covid beneficiary Velocity Clinical Research explores sale, L Catterton invests in Birkinstock, First-timer Twist joins SPAC game

New tech-focused SPAC Twist Capital is targeting $175 million and L Catterton backs Birkinstock.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this